Pfizer wins legal case to keep Viagra patent

By Admin
Global drug giant Pfizer has won a legal case preventing Teva Pharmaceutical Industries Ltd (TEVA) from producing generic versions of its impotence dru...

Global drug giant Pfizer has won a legal case preventing Teva Pharmaceutical Industries Ltd (TEVA) from producing generic versions of its impotence drug Viagra.  

A US court ruled the patent Pfizer holds for Viagra is valid until 2019, stopping any other companies from manufacturing unbranded versions.

The decision is likely to come as a huge boost to Pfizer, as sales of Viagra earn the company approximately $1 billion in US revenues alone.

READ MORE FROM THE WDM CONTENT NETWORK:

To read the latest edition of Healthcare Global, click here

Amy Schulman, the Executive Vice President and General Counsel for Pfizer, said about the ruling: “We are pleased that the court recognised the validity and enforceability of our Viagra patent for the treatment of erectile dysfunction.”

 “Protecting the intellectual property rights of our innovative core is critical, and Friday's court decision acknowledges Teva's clear violation of our patent rights.”

Within the next two years Pfizer is due to lose the patent on some of its best-selling pharmaceuticals and drugs, resulting in a huge loss of revenue for the company.

In November Pfizer will lose the exclusive rights to Liptor, its best selling cholesterol drug.

As a result of the imminent expiry of patents, Pfizer has had to cut funding in research and new drug development to help it to cope with the reduction in revenue.

Share

Featured Articles

Digital healthcare platform Balanced supports healthy ageing

10,000 people turn 65 in the USA each day. Digital healthcare platform Balanced wants to help them better manage healthy ageing, says CEO Katie Reed

TrueBinding’s antibody drugs fight Alzheimer’s Disease

Dongxu Sun, CEO at TrueBinding, shares how its research & antibody drug development is fighting illnesses such as Alzheimer’s Disease, stroke & more

Cardinal Health’s clinically integrated pharma supply chain

Peter J. Siavelis, SVP & General Manager, Health System & Provider Distribution & Services at Cardinal Health, discusses the integrated pharma supply chain

Healthcare Digital news roundup: digital healthcare & AI

Digital Healthcare

Hospitals must embrace IoMT device security

Hospitals

Mental health support for working women and mothers

Digital Healthcare